News
Media
Conference
Publication
CME/CE
Partners
Resources
Contribute
Subscribe
Clinical Forum Insights

December 2016

Recent Insights in Understanding the Clinical Impact and Burden of Carbapenem-Resistant Enterobacteriaceae

ByKeith S. Kaye, MD, MPH,Lynn E. Connolly, MD, PhD

January 1st 2017

Antimicrobial Stewardship Standards: A Comparison of Centers for Medicare & Medicaid Services and Joint Commission Requirements

ByZahra Kassamali, PharmD, BCPS

January 1st 2017

Why Is TB Still Such a Big Threat in the United States?

ByDorothy McCoy, PharmD, BCPS-AQ ID

January 1st 2017

Epclusa: What Have We Learned?

ByAmanda Binkley, PharmD, AAHIVP,Ashley Sheridan, PharmD

January 1st 2017

What Issues Are We Still Facing with Curing HIV?

ByKengo Inagaki, MD

January 1st 2017

Innovation Is the Key to a Healthy Future

ByMike Hennessy, Sr, Chairman,CEO

January 1st 2017

Antimicrobial Stewardship and Telehealth for Critical Access and Regional Hospitals

ByRYAN W. STEVENS, PHARMD, BCPS

January 1st 2017

Guideline Updates for Infective Endocarditis, HAP, and VAP

ByPolly Jen, PharmD, BCPS-AQ ID, AAHIVP,Elizabeth Leung, PharmD, BCPS-AQ ID

January 1st 2017

Trending on Contagion Live

Bepirovirsen Phase 3 Results Offer Potential Cure for Chronic Hepatitis B

Review of Cefepime and Zidebactam: A Novel Antibiotic Approved to Treat Complicated Urinary Tract Infections

Vaccine for Lassa Fever Succeeds in First-in-Human Trial

FDA Expands Merck Pneumococcal Vaccine Indication to Include At-Risk Children and Adolescents

FDA Approves Tebipenem Pivoxil as First Oral Carbapenem For Complicated Urinary Tract Infections